Civil society involvement in harm reduction drug policy: reflections on the past, expectations for the future. [PDF]
Harm Reduct J, 2021 O'Gorman A, Schatz E.
europepmc +1 more source
Market Structure and Drug Innovation [PDF]
An explosion of knowledge and a growing array of tools and technologies have transformed modern drug R&D, while its cost has risen by a sizable amount.
Pammolli, Fabio, Riccaboni, Massimo
core +1 more source
Advanced Science, EarlyView.This study elucidates a novel mechanistic role of the deubiquitinase OTUD6A in asthma pathogenesis, uncovering its regulatory function in airway inflammation and airway remodeling through the stabilization of hResistin/mRELMα. This study offers a novel regulatory axis (OTUD6A‐hResistin/mRELMα) in asthma pathogenesis and OTUD6A inhibition as a potential
Weiting Pan +10 more
wiley +1 more source
US drug policy does not align with experts' rankings of drug harms: a multi-criteria decision analysis. [PDF]
Harm Reduct JBroman M +20 more
europepmc +1 more source
An ethical analysis of UK drug policy as an example of a criminal justice approach to drugs: a commentary on the short film Putting UK Drug Policy into Focus. [PDF]
Harm Reduct J, 2020 Holland A.
europepmc +1 more source
A Social Insurance Model for Pharmacare: Ontario's Options for a More Sustainable, Cost-Effective Drug Program [PDF]
With annual spending of about $4.5 billion dollars in 2010, Canada’s largest drug plan – the Ontario Drug Program (ODB) – will become harder to afford as the babyboomers age and workforce growth slows.
Colin Busby, William B.P. Robson
core
All‐PEG‐Like Block Copolymers Self‐Assemble into Stealth Nanocarriers for Drug Delivery
Advanced Science, EarlyView.Self‐assembling nanoparticles composed entirely of POEGMA are engineered by exploiting side‐chain–dependent amphiphilicity and tunable thermoresponsive behavior. These single‐material nanocarriers encapsulate diverse hydrophobic drugs with high efficiency, retain therapeutic activity, improve in vivo efficacy, and evade anti‐PEG antibodies.
Parul Sirohi +15 more
wiley +1 more source
Counting the savings: impact of Georgia's drug policy interventions on households. [PDF]
Int J Equity HealthGorgodze T, Zoidze A, Gotsadze G.
europepmc +1 more source
Abstinence, anti-drug psychosocial care centers and therapeutic communities: pillars for reorienting the Brazilian Mental Health and Drug Policy. [PDF]
Braz J Psychiatry, 2021 Weber CA +3 more
europepmc +1 more source